X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
suv-based assessment (80) 80
positron-emission-tomography (58) 58
index medicus (50) 50
humans (47) 47
fdg-pet (46) 46
oncology (40) 40
f-18-fdg pet (39) 39
non-hodgkins-lymphoma (36) 36
b-cell lymphoma (35) 35
prognostic value (35) 35
response assessment (35) 35
hematology (31) 31
prognosis (31) 31
radiology, nuclear medicine & medical imaging (29) 29
fluorodeoxyglucose f18 (28) 28
lymphoma (27) 27
chemotherapy (23) 23
international workshop (22) 22
lymphomas (21) 21
positron-emission tomography (21) 21
female (19) 19
male (19) 19
adult (18) 18
aged (18) 18
middle aged (18) 18
positron-emission tomography - methods (18) 18
tomography, x-ray computed (18) 18
lymphoma, large b-cell, diffuse - diagnostic imaging (17) 17
pet imaging (17) 17
positron emission tomography (15) 15
treatment outcome (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
early f-18-fdg pet (14) 14
radiopharmaceuticals (14) 14
criteria (12) 12
lymphoma, large b-cell, diffuse - drug therapy (12) 12
malignant-lymphoma (12) 12
rituximab (12) 12
diffuse large b-cell lymphoma (11) 11
interim pet (11) 11
metabolic tumor volume (11) 11
aggressive lymphoma (10) 10
cancer (10) 10
lymphoma, large b-cell, diffuse - therapy (10) 10
medicine & public health (10) 10
neoplasm staging (10) 10
tomography (10) 10
interim f-18-fdg pet (9) 9
international harmonization project (9) 9
multimodal imaging (9) 9
nuclear medicine (9) 9
pet (9) 9
progression-free (9) 9
lymphoma - diagnostic imaging (8) 8
lymphoma, large b-cell, diffuse - mortality (8) 8
non-hodgkin-lymphoma (8) 8
young adult (8) 8
care and treatment (7) 7
cycles (7) 7
elderly-patients (7) 7
imaging / radiology (7) 7
scans (7) 7
tumors (7) 7
aged, 80 and over (6) 6
bone-marrow involvement (6) 6
cardiology (6) 6
disease-free survival (6) 6
hematology, oncology and palliative medicine (6) 6
high-dose chemotherapy (6) 6
interim (6) 6
interim pet/ct (6) 6
international prognostic index (6) 6
lymphoma - therapy (6) 6
lymphoma, large b-cell, diffuse - diagnosis (6) 6
orthopedics (6) 6
pathology (6) 6
pet/ct (6) 6
suv (6) 6
therapy (6) 6
3 cycles (5) 5
adolescent (5) 5
antibodies, monoclonal, murine-derived - therapeutic use (5) 5
cyclophosphamide - therapeutic use (5) 5
doxorubicin - therapeutic use (5) 5
hodgkins-lymphoma (5) 5
liver (5) 5
lymphoma - pathology (5) 5
positron-emission tomography - standards (5) 5
prediction (5) 5
predictive value of tests (5) 5
prednisone - therapeutic use (5) 5
sensitivity and specificity (5) 5
stage hodgkins lymphoma (5) 5
survival (5) 5
vincristine - therapeutic use (5) 5
abridged index medicus (4) 4
analysis (4) 4
antibodies, monoclonal, murine-derived - administration & dosage (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
clinical trials (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ONCOLOGY (United States), ISSN 0890-9091, 2017, Volume 31, Issue 1, pp. 71 - 76
In Part 1, we reviewed the role of interim positron emission tomography (PET)/CT scans in Hodgkin lymphoma. In advanced Hodgkin lymphoma, interim PET is a... 
POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | INTERNATIONAL PROGNOSTIC INDEX | INTERIM PET | NON-HODGKINS-LYMPHOMA | PROGRESSION-FREE | PREDICTIVE-VALUE | QUANTIZATION PARAMETERS | CHEMOTHERAPY PLUS RITUXIMAB | SUV-BASED ASSESSMENT | METABOLIC TUMOR VOLUME
Journal Article
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 06/2014, Volume 55, Issue 6, pp. 911 - 916
In a prospective study of newly diagnosed or relapsed histologically proven extranodal natural killer/T-cell lymphoma (ENKTL) patients, we aimed to determine... 
FDG-PET | F-18-FDG PET/CT | Deauville score (DS) | CONSENSUS | extranodal natural killer/T-cell lymphoma (ENKTL) | PROGNOSTIC VALUE | METABOLIC TUMOR VOLUME | INTERIM-PET | POSITRON-EMISSION-TOMOGRAPHY | INTERNATIONAL WORKSHOP | MATURE T-CELL | response assessment | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SUV-BASED ASSESSMENT
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 8/2010, Volume 51, Issue S1, pp. 28 - 33
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 9, pp. 2066 - 2073
Journal Article
EUROPEAN JOURNAL OF CANCER, ISSN 0959-8049, 06/2011, Volume 47, Issue 9, pp. 1312 - 1318
Purpose: F-18-fluoro-2-dexoy-D-glucose-positron emission tomography (FDG-PET)/computerised tomography (CT) has been used for staging and monitoring responses... 
FDG-PET | SURVIVAL | RESPONSE ASSESSMENT | Interim PET/CT | Rituximab | FLUORODEOXYGLUCOSE | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | Predictable value | DISEASE | Diffuse large B cell lymphoma | NON-HODGKINS-LYMPHOMA | PROGRESSION-FREE | F-18-FLUORODEOXYGLUCOSE | SUV-BASED ASSESSMENT
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 12/2010, Volume 51, Issue 12, pp. 1857 - 1862
This study investigated whether the reference background above which a residual mass is considered positive in the International Harmonization Project criteria... 
FDG-PET | CRITERIA | INTERIM | lymphoma | RESPONSE ASSESSMENT | STAGE HODGKINS LYMPHOMA | prognosis | CHEMOTHERAPY | POSITRON-EMISSION-TOMOGRAPHY | INTERNATIONAL WORKSHOP | THERAPY | response | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | SUV-BASED ASSESSMENT
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 11/2014, Volume 167, Issue 3, pp. 327 - 336
We conducted a multicentre, phase II study of interim positron emission tomography (PET) as a guide to risk-adapted therapy in high-risk patients with newly... 
ADAPTED THERAPY | lymphoma | autologous stem cell transplantation | RESPONSE ASSESSMENT | PROGNOSTIC VALUE | F-18-FDG PET | POSITRON-EMISSION-TOMOGRAPHY | INTERNATIONAL WORKSHOP | fluorodeoxyglucose positron emission tomography | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | ELDERLY-PATIENTS | SUV-BASED ASSESSMENT | DES-LYMPHOMES
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 01/2019, Volume 60, Issue 2, pp. 302 - 308
The Deauville criteria (DC) shall always be used to report interim and final PET and to assign metabolic response categories in FDG-avid lymphoma. A recent... 
Deauville criteria | quantitative criteria | Response assessment | lymphoma | FDG-PET | CRITERIA | GUIDELINES | HODGKIN-LYMPHOMA | CONCORDANCE | PROGNOSTIC VALUE | B-CELL LYMPHOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | INTERIM F-18-FDG PET | HEMATOLOGY | SUV-BASED ASSESSMENT
Journal Article
CANCER, ISSN 0008-543X, 03/2011, Volume 117, Issue 5, pp. 1010 - 1018
Journal Article
Journal Article